Granules India Share Value Rises 4% in today’s intraday trade:
To begin with, today, the share value of the Granules India increased by 4% in intraday trade. The company received approval for the Potassium Chloride Extended medicine from USFDA after that, its share values raised.
The extended medicine received approval from USFDA, the drug which has filed by Granules Pharmaceuticals. The Potassium Chloride Extended-Release Tablets completely owned by the foreign subsidiary company. The companion of theses drug is 8 mEq-600 mg and 10mEq-750 mg of Upsher-Smith Laboratories, LLC.
Moreover, it has one of the references traded drug products for Klor-Con Extended-Released Tablets. Totaly, the company has 24 ANDA approvals, in these 22 final approvals and the remaining 2 are tentative approvals from USFDA.
Granules India Ltd shares trading with a gain of 5.80 points reached 177.80 INR with a 3.37% rise. Its previous close at 172.00 INR. Granules India Ltd shares outstanding with 254,248,000.
